SLC6A6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.356200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.627200E-01
Normal-vs-Stage2
8.389600E-01
Normal-vs-Stage3
2.431400E-01
Normal-vs-Stage4
2.458000E-01
Stage1-vs-Stage2
1.217880E-03
Stage1-vs-Stage3
4.365600E-01
Stage1-vs-Stage4
1.046200E-01
Stage2-vs-Stage3
1.600980E-01
Stage2-vs-Stage4
3.463900E-02
Stage3-vs-Stage4
4.820400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.541600E-01
Normal-vs-AfricanAmerican
9.194600E-01
Normal-vs-Asian
9.932000E-01
Caucasian-vs-AfricanAmerican
7.884200E-01
Caucasian-vs-Asian
9.274600E-01
AfricanAmerican-vs-Asian
8.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.599000E-01
Normal-vs-Female
9.094000E-01
Male-vs-Female
7.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.962000E-01
Normal-vs-Age(41-60Yrs)
6.016000E-01
Normal-vs-Age(61-80Yrs)
9.367800E-01
Normal-vs-Age(81-100Yrs)
4.571400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.981800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.414800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.676400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.271500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.420400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.842200E-01
Normal-vs-Daily Drinker
8.081400E-01
Normal-vs-Weekly Drinker
9.396600E-01
Normal-vs-Occasional Drinker
9.379600E-01
Normal-vs-Social Drinker
9.585200E-01
Non Drinker-vs-Daily Drinker
8.143400E-01
Non Drinker-vs-Weekly Drinker
4.059800E-01
Non Drinker-vs-Occasional Drinker
3.536200E-01
Non Drinker-vs-Social Drinker
3.757200E-01
Daily Drinker-vs-Weekly Drinker
5.823200E-01
Daily Drinker-vs-Occasional Drinker
5.420400E-01
Daily Drinker-vs-Social Drinker
5.741200E-01
Weekly Drinker-vs-Occasional Drinker
9.859800E-01
Weekly Drinker-vs-Social Drinker
9.374600E-01
Occasional Drinker-vs-Social Drinker
9.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.334000E-01
Normal-vs-Grade 2
3.837500E-02
Normal-vs-Grade 3
4.720000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.941150E-03
Grade 1-vs-Grade 3
5.754400E-02
Grade 1-vs-Grade 4
3.334000E-01
Grade 2-vs-Grade 3
1.505590E-01
Grade 2-vs-Grade 4
3.837500E-02
Grade 3-vs-Grade 4
4.720000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.769200E-01
Normal-vs-NonDiabetic
9.933000E-01
Diabetic-vs-NonDiabetic
6.156600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.524600E-01
Normal-vs-NoPancreatitis
9.848800E-01
Pancreatitis-vs-NoPancreatitis
7.243000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.715600E-01
Normal-vs-N1
8.290600E-01
N0-vs-N1
1.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.148400E-01
Normal-vs-TP53-NonMutant
6.549200E-01
TP53-Mutant-vs-TP53-NonMutant
6.859500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
